Kelajakdagi narxning foydaga nisbati: Avalon GloboCare (ALBT)

Avalon GloboCare Corporation - ALBT emitenti grafik logotipi

Avalon GloboCare IT xizmatlari va logistikani uchinchi tomon pudratchilariga topshirish orqali xarajatlarni optimallashtirmoqda. Kompaniyaning GURU.Markets grafigidagi joriy forward P/E ko'rsatkichi ushbu tendentsiyani tasdiqlaydi, bunda 0.00 metriki baholash parametrining holatini belgilaydi. O'sish istiqbollari AQShda diagnostika xizmatlarining kengayishi va tadqiqot xodimlarining kuchaytirilishiga asoslangan bo'lib, bu hujayra terapiyalarini kengaytirish uchun poydevor yaratadi.

Avalon GloboCare - ALBT Kapitalizatsiyaning kelajakdagi foydaga nisbati (davr: 28.04.2023 - 22.07.2026)

Avalon GloboCare (ALBT) kompaniyasining tahliliy kesimlari

- kotirovkalar va tahlilchilar prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:ALBT Avalon GloboCare Corporation
Avalon GloboCare Corporation tovar namunasi

Forward P/E ko'rsatkichi aksiyaning joriy bozor qiymatining prognoz qilingan aksiya boshiga foyda miqdoriga nisbati sifatida hisoblanadi va bu investor kelajakdagi daromadlar uchun qanchalik ortiqcha to'lov qilayotganini o'lchaydi. Ushbu nisbat likvidlik va o'sish kutsivlari o'rtasidagi muvozanatni aks ettiradi, bunda Avalon GloboCare tomonidan hujayra biologlaridan iborat yuqori maoshli xodimlarga kiritilgan investitsiyalar terapiyani tijaratlashtirish imkoniyati orqali kompaniyaning kelajakdagi P/E darajasiga bevosita ta'sir ko'rsatadi.

Raqobatdosh kompaniyalar

Kelajakdagi narxning foydaga nisbati HCA Holdings (HCA)|Tenet Healthcare - Narxning kelajakdagi foydaga nisbati|Fresenius Medical Care Corp - Prognoz qilingan narxning foydaga nisbati|SOLV: Narxning kelajakdagi foydaga nisbati|Encompass - Forvard P/E multiplikatori|UHS - Forvard P/E multiplikatori|DVA: Forvard P/E multiplikatori|RadNet Corp - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Option Care Health Inc|Forvard P/E multiplikatori surgerypartners.com|Forvard P/E multiplikatori PINC|Kapitalizatsiyaning prognoz qilingan foydaga nisbati National Vision Holdings, Inc.|Forvard P/E multiplikatori PGNY (Progyny Inc)|Ardent Health Corp (ARDT) - Prognoz qilingan narx-foyda nisbati|SEM: Prognoz qilingan narxning foydaga nisbati|ASTH - Forvard P/E multiplikatori|MD: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati USPH (US Physical Therapy)|Kelajakdagi narxning foydaga nisbati The Pennant Group, Inc.|ORGO - Forvard narx-foyda multiplikatori|Forvard P/E multiplikatori NUTX|Forvard P/E multiplikatori Auna (AUNA)|Forvard P/E multiplikatori SBC (sbc-holdings.com)|EOLS: Narxning kelajakdagi foydaga nisbati|Community Health Systems Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati The Beauty Health Company|MediWound Ltd (MDWD) - Kelajakdagi narxning foydaga nisbati|BTMD - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati The Joint|Prognoz qilingan narxning foydaga nisbati DocGo (DCGO)|P3 Health Partners, Inc. (PIII) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori Gain Therapeutics (GANX)|Forvard P/E multiplikatori EUDA (EUDA Health)|Kelajakdagi narx-foyda multiplikatori BMGL|CollPlant Ltd - Forvard P/E multiplikatori|Forvard narx-foyda multiplikatori Cuprina Holdings (Cayman) Ltd. (CUPR)|Concord Medical Corp (CCM) - Kelajakdagi narxning foydaga nisbati|ASHS - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati MEDIROM Healthcare Group|Narxning kelajakdagi foydaga nisbati DHAI (DIH Holding US, Inc.)|Forvard P/E multiplikatori XAGE|Kapitalizatsiyaning prognoz qilingan foydaga nisbati NewGenIvf Group|Kelajakdagi narxning foydaga nisbati ATI Physical Therapy Inc. ATIP|CareMax Medical Group (CMAX) - Prognoz qilingan narx-foyda nisbati|KDLY - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori MODV (ModivCare Inc.)|Novo Integrated (NVOS) - Kelajakdagi narxning foydaga nisbati|SSY - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati IMAC Holdings Inc